Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

AUPH holding history

Aurinia Pharmaceuticals Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AUPH overviewAll 13F holders of AUPHFull Q2 2026 holdings

Shares (Q2 2026)
19,830
Value
$336.5K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of AUPH by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202619,830$336.5K<0.1%−3,421−14.7%ReducedHolders
Q1 202623,251$344.6K<0.1%−4,390−15.9%ReducedHolders
Q4 202527,641$440.9K<0.1%+3,039+12.4%AddedHolders
Q3 202524,602$271.9K<0.1%−4,597−15.7%ReducedHolders
Q2 202529,199$247.3K<0.1%−6,057−17.2%ReducedHolders
Q1 202535,256$283.5K<0.1%−9,332−20.9%ReducedHolders
Q4 202444,588$400.4K<0.1%+10,771+31.9%AddedHolders
Q3 202433,817$247.9K<0.1%+6,850+25.4%AddedHolders
Q2 202426,967$154.0K<0.1%−7,497−21.8%ReducedHolders
Q1 202434,464$172.7K<0.1%+2,873+9.1%AddedHolders
Q4 202331,591$284.0K<0.1%+4,624+17.1%AddedHolders
Q3 202326,967$209.5K<0.1%+100+0.4%AddedHolders
Q2 202326,867$260.1K<0.1%+1,194+4.7%AddedHolders
Q1 202325,673$281.4K<0.1%−3,341−11.5%ReducedHolders
Q4 202229,014$125.3K<0.1%+2,290+8.6%AddedHolders
Q3 202226,724$202.0K<0.1%+620+2.4%AddedHolders
Q2 202226,104$262.0K<0.1%+11,444+78.1%AddedHolders
Q1 202214,660$181.0K<0.1%−3,601−19.7%ReducedHolders
Q4 202118,261$418.0K<0.1%−9,168−33.4%ReducedHolders
Q3 202127,429$607.0K<0.1%+4,402+19.1%AddedHolders
Q2 202123,027$298.0K<0.1%+5,394+30.6%AddedHolders
Q1 202117,633$229.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.